Avalo Therapeutics - M&A Summary and Business Overview

Life ScienceCompany

Avalo Therapeutics M&A Summary

Avalo Therapeutics has acquired 1 company, including 1 in the last 5 years.

Avalo Therapeutics’ largest acquisition to date was in 2019, when it acquired Aevi Genomic Medicine for $23M. Avalo Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Avalo Therapeutics Business Overview

Where is Avalo Therapeutics headquartered?

Avalo Therapeutics is headquartered in Rockville, Maryland.

What is Avalo Therapeutics’ revenue?

Avalo Therapeutics disclosed revenue of 2M USD for 2023 and 18M USD for 2022.

How many employees does Avalo Therapeutics have?

Avalo Therapeutics has 19 employees.

What sector is Avalo Therapeutics in?

Avalo Therapeutics is a life science company.

When was Avalo Therapeutics founded?

Avalo Therapeutics was founded in 2011.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 1

Avalo Therapeutics

Avalo Therapeutics, Inc.,

540 Gaither Road Suite 400,
Rockville, Maryland 20850
United States,
(410) 522-8707
www.avalotx.com

Avalo Therapeutics is a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan diseases, as well as neurological conditions. Avalo Therapeutics, Inc. is building a robust pipeline of innovative therapies. Avalo Therapeutics's pediatric rare disease pipeline is led by CERC-801, CERC-802, and CERC-803 (“CERC-800 programs”), which are therapies for inborn errors of metabolism, specifically disorders known as Congenital Disorders of Glycosylation. The FDA granted Rare Pediatric Disease Designation and Orphan Drug Designation (“ODD”) to all three CERC-800 compounds, thus qualifying the Company to receive a Priority Review Voucher (“PRV”) upon approval of a new drug application (“NDA”). Avalo Therapeutics was founded in 2011 and is based in Rockville, Maryland.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $23M $23M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Aevi Genomic Medicine, Inc. 2019-12-05 23M USD Add-on Acquisition
Wayne, Pennsylvania · www.aevigenomics.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 23M (100%) - -
Total 1 $23M - -

By Geo

State/Country Buy Value Sell Value
United States 1 23M - -
  Pennsylvania 1 23M - -
Total 1 $23M - -

Top M&A Advisors

Legal Deals
Wyrick Robbins Yates & Ponton LLP
 1

Deal Values

buy # Total
< $100M 1 $23M
TOTAL $23M
Largest Aevi Genomic Medicine, Inc.
$23M (2019-12-05)

Company Summary

SECTOR

Life Science

Revenue

2   89% 2023
18   260% 2022
5   29% 2021
7   0% 2020
7   62% 2019
18   36% 2018
28   2700% 2017
1   2016
(millions of USD) Show More Show Less

Employees

19

Established

2011

Public

NASDAQ: AVTX

Former Name

Cerecor, Inc. (Ceregen Corp.)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Avalo Therapeutics

Maryland Companies , Life Science Companies , United States Companies , Maryland Life Science Companies , Maryland Life Science with Acquisitions , Maryland Life Science with Divestitures

Related Lists for Maryland Companies

Largest Maryland Companies , Acquisitive Maryland Companies , Recently Acquired Maryland Companies , Recently Sold Maryland Companies , Private Maryland Companies , Public Maryland Companies , Acquired Maryland Companies , PE Backed Maryland Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal